High Mean Fluorescence Intensity Donor‐Specific Anti‐HLA Antibodies Associated With Chronic Rejection Postliver Transplant von O’Leary, J. G., Kaneku, H., Susskind, B. M., Jennings, L. W., Neri, M. A., Davis, G. L., Klintmalm, G. B., Terasaki, P. I.

Volltext

Limiting Hepatitis C Virus Progression in Liver Transplant Recipients Using Sirolimus‐Based Immunosuppression von McKenna, G. J., Trotter, J. F., Klintmalm, E., Onaca, N., Ruiz, R., Jennings, L. W., Neri, M., O’Leary, J. G., Davis, G. L., Levy, M. F., Goldstein, R. M., Klintmalm, G. B.

Volltext

The Impact of Treatment of Portopulmonary Hypertension on Survival Following Liver Transplantation von Ashfaq, M., Chinnakotla, S., Rogers, L., Ausloos, K., Saadeh, S., Klintmalm, G. B., Ramsay, M., Davis, G. L.

Volltext

A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults von Davis, L.M.G., Martínez, I., Walter, J., Hutkins, R.

Volltext

Factors predictive of a beneficial response to therapy of hepatitis C von Davis, G L, Lau, J Y

Volltext

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C von Davis, Gary L, Esteban-Mur, Rafael, Rustgi, Vinod, Hoefs, John, Gordon, Stuart C, Trepo, Christian, Shiffman, Mitchell L, Zeuzem, Stefan, Craxi, Antonio, Ling, Mei-Hsiu, Albrecht, Janice

Volltext

Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis von SNOWBERGER, N., CHINNAKOTLA, S., LEPE, R. M., PEATTIE, J., GOLDSTEIN, R., KLINTMALM, G. B., DAVIS, G. L.

Volltext

Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial von Bodenheimer, H C, Lindsay, K L, Davis, G L, Lewis, J H, Thung, S N, Seeff, L B

Volltext

QTL associated with Fusarium head blight resistance in the soft red winter wheat Ernie von Liu, S, Abate, Z. A, Lu, H, Musket, T, Davis, G. L, McKendry, A. L

Volltext

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders von Nelson, David R., Lauwers, Gregory Y., Lau, Johnson Y.N., Davis, Gary L.

Volltext

maize map standard with sequenced core markers, grass genome reference points and 932 expressed sequence tagged sites (ESTs) in a 1736-locus map von Davis, G.L, McMullen, M.D, Baysdorfer, C, Musket, T, Grant, D, Staebell, M, Xu, G, Polacco, M, Koster, L, Melia-Hancock, S, Houchins, K, Chao, S, Coe, E.H. Jr

Volltext

Response to Comment on "Late Upper Paleolithic occupation at Cooper's Ferry, Idaho, USA, ~16,000 years ago" von Davis, L G, Becerra-Valdivia, L, Madsen, D B, Higham, T

Volltext

European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018–2019: results from T... von Viprey, V.F., Granata, G., Vendrik, K.E.W., Davis, G.L., Petrosillo, N., Kuijper, E.J., Vilken, T., Lammens, C., Schotsman, J.J., Benson, A.D., Cataldo, M.A., van der Kooi, T.I.I., Wilcox, M.H., Davies, K.A.

Volltext

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C von Lau, J.Y.N, Davis, G.L, Kniffen, J, Qian, K.-P, Urdea, M.S, Chan, C.S, Neuwald, P.D, Wilber, J.C, Mizokami, M

Volltext

Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection... von Davies, Kerrie A, Ashwin, Helen, Longshaw, Christopher M, Burns, David A, Davis, Georgina L, Wilcox, Mark H

Volltext

Current therapy for chronic hepatitis C von Davis, Gary L.

Volltext

Sex-specific expression of gastrin-releasing peptide receptor : Relationship to smoking history and risk of lung cancer von SHRIVER, S. P, BOURDEAU, H. A, GUBISH, C. T, TIRPAK, D. L, DAVIS, A. L. G, LUKETICH, J. D, SIEGFRIED, J. M

Volltext

Treatment of chronic hepatitis C von Davis, Gary L

Volltext

Clinical trial: interferon alpha‐2b continuous long‐term therapy vs. repeated 24‐week cycles for re‐treating chronic hepatitis C von MCHUTCHISON, J. G., PATEL, K., SCHIFF, E. R., GITLIN, N., MUR, R. E., EVERSON, G. T., CARITHERS, R. L., DAVIS, G. L., MARCELLIN, P., SHIFFMAN, M. L., HARVEY, J., ALBRECHT, J. K.

Volltext

Intrahepatic hepatitis C virus–specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C von Nelson, David R., Marousis, Constantine G., Ohno, Tomoyoshi, Davis, Gary L., Lau, Johnson Y.N.

Volltext